Friday, February 24, 2017 6:20:55 PM
http://mobile.reuters.com/article/amp/idUSTRE7450SV20110506
Many doctors aren't happy with so many clinical trials taking place overseas (61% in this Reuters article) but its all about keeping costs down.
Many companies are selling new medicines in Asia, EU and South America, to help fund FDA trials.
I think the old bio tech model of IPO'ing at $50 a share and then praying the money doesn't run out before Phase 3 starts is a broken model. Who buys those IPOs now? They just go down and down and down.
Know What You Own. My posts should not be construed as investment advice.
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM